Ono, R., Nakayama, K., Nakamura, K., Yamashita, H., Ishibashi, T., Ishikawa, M., . . . Kyo, S. (2019). Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies). MDPI AG.
Citação norma ChicagoOno, Ruriko, et al. Dedifferentiated Endometrial Carcinoma Could Be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies). MDPI AG, 2019.
Citação norma MLAOno, Ruriko, et al. Dedifferentiated Endometrial Carcinoma Could Be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies). MDPI AG, 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.